Gene Synthesis Market Size, Share & Industry Analysis, By Method (Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis), By Service, By Application, By End-use, By Region, and Regional Forecast, 2026-2034

The gene synthesis market size was valued at USD 2.81 billion in 2025. The market is projected to grow from USD 3.27 billion in 2026 to USD 10.99 billion by 2034, exhibiting a CAGR of 16.36% during the forecast period. The market in North America dominated with a revenue share of  42% in 2025.

The gene synthesis market is expanding rapidly due to increasing demand for synthetic biology, precision medicine, genetic engineering, and advanced biotechnology research. Gene synthesis technologies enable researchers to create customized DNA sequences for applications in pharmaceuticals, vaccine development, agricultural biotechnology, and industrial enzymes. Healthcare and life sciences organizations increasingly rely on synthetic genes to accelerate drug discovery, molecular diagnostics, and therapeutic innovation. The gene synthesis market growth is also supported by advancements in automation, artificial intelligence, and high-throughput DNA synthesis technologies. Demand for accurate, scalable, and cost-efficient synthetic gene manufacturing services continues to increase across biotechnology companies, academic institutes, and pharmaceutical organizations worldwide.

The USA gene synthesis market remains a leading global industry due to advanced biotechnology infrastructure, strong pharmaceutical research activity, and substantial investment in genomics innovation. Biotechnology firms and research laboratories increasingly utilize gene synthesis services for CRISPR development, vaccine research, and personalized medicine applications. Synthetic biology startups and pharmaceutical companies continue to strengthen market demand for rapid and customized DNA synthesis solutions. The United States accounts for approximately 40% of the North American gene synthesis market Share because of strong research funding and increasing adoption of genomic technologies. The gene synthesis market report for the USA highlights growing investment in AI-driven gene design platforms and automated synthesis systems.

Gene Synthesis Market Key Takeaways

 Global Market Size & Forecast

• 2025 Market Size: USD 2.81 Billion
• 2026 Market Size: USD 3.27 Billion
• 2034 Forecast Market Size: USD 10.99 Billion
• CAGR: 16.36% from 2026-2034

Market Share

• The market in North America dominated with a revenue share of 42% in 2025.
• Custom gene synthesis services accounted for approximately 48% of the market.
• Solid-phase synthesis accounted for approximately 46% of the market.

Key Regional Highlights

Asia-Pacific

Asia-Pacific represented 24% of the market, led by China and Japan.

North America

North America held the largest regional market share at 42% in 2025.

Europe

Europe accounted for 27% of the global market, with Germany leading the region.

U.S.

The U.S. remains a key market driven by biotechnology research and therapeutic development.

Japan

Japan accounted for approximately 18% of the Asia-Pacific gene synthesis market.

Read More

gene synthesis market Latest Trends

The gene synthesis market trends indicate strong movement toward automation, AI-driven sequence optimization, and high-throughput synthetic biology workflows. Biotechnology companies increasingly deploy automated gene synthesis platforms capable of reducing turnaround times and improving sequence accuracy. Artificial intelligence and machine learning technologies are also enhancing gene design processes by improving codon optimization and minimizing synthesis errors.

Download Free sample to learn more about this report.

Another major trend shaping the gene synthesis market analysis is the growing adoption of synthetic biology in pharmaceutical development, vaccine production, and agricultural biotechnology. Researchers increasingly utilize synthetic genes for protein engineering, cell therapy development, and advanced molecular diagnostics. Cloud-based bioinformatics platforms and digital laboratory systems are streamlining research workflows and improving collaboration across global research institutions. In addition, demand for long DNA constructs and custom gene libraries is increasing due to expanding genomic research and personalized medicine applications. The integration of CRISPR technologies and next-generation sequencing continues to drive innovation across the global gene synthesis industry.

gene synthesis market Dynamics

DRIVER

Increasing Demand for Synthetic Biology and Precision Medicine

The growing use of synthetic biology and personalized medicine is one of the primary drivers accelerating gene synthesis market Growth. Pharmaceutical companies, biotechnology firms, and academic research organizations increasingly rely on synthetic genes to support drug discovery, vaccine development, and advanced genomic engineering. Gene synthesis technologies provide precise DNA customization capabilities that improve research efficiency and accelerate therapeutic development timelines.

The gene synthesis market Research Report also highlights increasing adoption of CRISPR-based gene editing and cell therapy applications. Researchers utilize synthetic DNA sequences for genetic modifications, protein engineering, and development of targeted therapies. Expansion of genomics research and rising investment in biotechnology infrastructure continue to strengthen market demand. Governments and healthcare organizations are also increasing support for genomic medicine initiatives and rare disease research programs. Automation technologies and AI-based gene design systems are further improving scalability, accuracy, and production efficiency across synthetic biology workflows.

RESTRAINT

High Synthesis Costs and Biosecurity Concerns

The gene synthesis market faces restraints associated with high production costs and growing concerns regarding biosecurity and ethical risks. Advanced DNA synthesis technologies require sophisticated laboratory infrastructure, automated equipment, and skilled scientific personnel, resulting in substantial operational expenses. Smaller biotechnology firms and research institutions may face budget limitations that restrict access to advanced gene synthesis services.

The Gene Synthesis Industry Analysis also identifies regulatory scrutiny and biosecurity risks as significant market challenges. Synthetic DNA technologies can potentially be misused for harmful biological applications, leading governments and regulatory organizations to implement strict screening and compliance requirements. Gene synthesis providers must continuously monitor customer orders and maintain sequence verification protocols to ensure biosafety. In addition, long DNA sequence synthesis remains technically complex and may result in higher error rates and production delays. These factors collectively impact operational efficiency and market expansion potential.

OPPORTUNITY

Expansion of Cell Therapy and Vaccine Development Applications

The increasing use of synthetic genes in cell therapy, immunotherapy, and vaccine development is creating substantial opportunities within the gene synthesis market. Pharmaceutical and biotechnology companies increasingly require customized DNA constructs for mRNA vaccines, CAR-T therapies, and targeted genetic treatments. Gene synthesis technologies accelerate therapeutic development by enabling rapid sequence optimization and scalable DNA production.

The gene synthesis market Opportunities are also expanding through agricultural biotechnology and industrial enzyme engineering applications. Researchers are developing genetically modified crops, microbial strains, and bio-based production systems using synthetic DNA technologies. Emerging markets are investing heavily in biotechnology research infrastructure and precision medicine initiatives, creating additional growth potential for gene synthesis providers. Companies are also focusing on cloud-integrated bioinformatics tools and automated synthesis platforms designed to improve workflow efficiency and reduce production timelines.

CHALLENGE

Regulatory Complexity and Sequence Accuracy Limitations

One of the major challenges affecting the gene synthesis market is ensuring regulatory compliance and maintaining high sequence accuracy across complex DNA constructs. Synthetic biology applications often require compliance with strict biosafety, intellectual property, and ethical guidelines, particularly for therapeutic and clinical research applications. Regulatory differences across countries can complicate international research collaborations and commercialization strategies.

The gene synthesis market Forecast also highlights technical challenges related to synthesizing long and complex DNA sequences with minimal errors. High GC-content regions, repetitive sequences, and large gene constructs may create synthesis difficulties and increase production costs. Manufacturers must continuously invest in advanced quality control systems and automation technologies to maintain reliability and competitiveness. Balancing innovation, regulatory compliance, and operational scalability remains a significant challenge for market participants.

gene synthesis market Segmentation

By Method

Solid-phase synthesis accounts for approximately 46% of the global gene synthesis market Share due to its widespread use in oligonucleotide production and custom DNA sequence generation. This method provides high synthesis accuracy and scalability, making it suitable for pharmaceutical research, molecular diagnostics, and synthetic biology applications. Biotechnology firms increasingly rely on solid-phase synthesis for gene assembly and therapeutic research projects.

The gene synthesis market Report highlights rising demand for automated solid-phase synthesis platforms capable of supporting high-throughput research workflows. Manufacturers are integrating AI-driven quality control systems and automated purification technologies to improve efficiency and reduce synthesis errors. Growth in genomics research and increasing demand for personalized medicine continue to strengthen segment expansion across global biotechnology industries.

Chip-based synthesis represents approximately 29% of the global gene synthesis market Size because of its ability to generate large numbers of DNA sequences simultaneously at reduced costs. This technology is increasingly utilized for synthetic gene libraries, CRISPR screening, and high-throughput genomics research applications. Researchers prefer chip-based synthesis because it enables efficient multiplexed DNA production and rapid experimental scalability.

The gene synthesis market insights indicate growing investment in microarray technologies and miniaturized DNA synthesis platforms designed for large-scale research operations. Academic institutes and biotechnology companies increasingly adopt chip-based systems to accelerate genomic screening and molecular engineering projects. Expansion of synthetic biology research and precision diagnostics continues to support segment growth.

PCR-based enzyme synthesis accounts for approximately 25% of the global gene synthesis market Share due to its flexibility and suitability for gene amplification and complex DNA assembly applications. This method is widely utilized in molecular cloning, vaccine research, and synthetic biology workflows requiring precise sequence modification and amplification.

The gene synthesis market Analysis highlights increasing adoption of PCR-based synthesis in pharmaceutical development and protein engineering applications. Researchers are integrating automated PCR systems and AI-driven optimization software to improve synthesis accuracy and operational productivity. Growth in cell therapy and immunotherapy research continues to create significant opportunities for PCR-based gene synthesis technologies.

To know how our report can help streamline your business, Speak to Analyst

By Service

Custom gene synthesis services contribute approximately 48% of the global gene synthesis market Share because pharmaceutical companies and research organizations increasingly require personalized DNA constructs for therapeutic and experimental applications. Service providers offer sequence optimization, codon engineering, cloning, and vector integration solutions tailored to client requirements. The gene synthesis market Growth in custom synthesis services is supported by increasing adoption of synthetic biology and personalized medicine technologies. Biotechnology companies increasingly outsource DNA synthesis activities to specialized providers with advanced automation capabilities and rapid turnaround times. Demand for custom synthetic genes in vaccine development and CRISPR research continues to strengthen segment expansion.

By Application

Therapeutics development represents approximately 39% of the global gene synthesis market Share because synthetic genes play a critical role in vaccine production, gene therapy, and biologics development. Pharmaceutical companies increasingly rely on gene synthesis technologies for rapid therapeutic design and molecular engineering applications. The gene synthesis market Opportunities within therapeutics development are increasing due to expansion of mRNA technologies, cell therapies, and precision medicine initiatives. Researchers utilize synthetic DNA constructs for targeted drug discovery and advanced immunotherapy development. Rising healthcare investment and biotechnology innovation continue to support strong market demand. Diagnostics applications account for approximately 23% of the global gene synthesis market because synthetic DNA technologies are increasingly utilized in molecular testing, genomic sequencing, and infectious disease diagnostics. Laboratories and diagnostic companies rely on synthetic genes for assay development and quality control standards.

The Gene Synthesis Industry Analysis highlights increasing integration of synthetic biology technologies into precision diagnostics and personalized healthcare systems. Demand for rapid genomic testing and AI-driven molecular diagnostics continues to strengthen segment expansion globally.

gene synthesis market Regional Outlook

North America

To get more information on the regional analysis of this market, Download Free sample

North America represents approximately 42% of the global gene synthesis market Share due to advanced biotechnology infrastructure, strong pharmaceutical research activity, and extensive genomic medicine adoption. The United States remains the dominant regional market because biotechnology companies and research organizations increasingly invest in synthetic biology and therapeutic innovation.

The gene synthesis market insights for North America highlight rising investment in AI-driven gene design systems, CRISPR technologies, and mRNA therapeutic development. Pharmaceutical firms and academic institutions continue to strengthen regional demand for rapid and scalable DNA synthesis solutions. Expansion of precision medicine initiatives and biotechnology funding programs further supports market growth.

Europe

Europe accounts for approximately 27% of the global gene synthesis market due to increasing genomic research activity, advanced healthcare systems, and strong pharmaceutical manufacturing capabilities. Countries including Germany, the United Kingdom, France, and Switzerland are major contributors to regional demand for synthetic biology technologies and custom gene synthesis services.

The gene synthesis market Analysis highlights growing focus on personalized medicine, vaccine research, and bioinformatics innovation across Europe. Governments and biotechnology organizations increasingly invest in genomics infrastructure and advanced laboratory automation systems. Rising demand for precision diagnostics and cell therapy development continues to strengthen regional market expansion.

Germany gene synthesis market

Germany contributes approximately 25% of the European gene synthesis market Share due to advanced biotechnology research infrastructure and strong pharmaceutical innovation capabilities. Research institutes and biotechnology companies increasingly deploy synthetic biology technologies for therapeutic development, vaccine research, and molecular engineering applications.

The Germany gene synthesis market Report highlights rising investment in AI-driven genomics platforms and automated DNA synthesis systems. Academic institutions and healthcare organizations continue to expand genomic medicine initiatives and personalized healthcare research programs. Germany’s strong life sciences ecosystem and biotechnology manufacturing expertise support long-term market growth.

United Kingdom gene synthesis market

The United Kingdom accounts for approximately 19% of the European gene synthesis market because of increasing biotechnology startup activity and strong government support for genomic research. Pharmaceutical companies and academic institutions increasingly utilize synthetic genes for precision diagnostics, therapeutic innovation, and synthetic biology applications.

The Gene Synthesis Industry Report for the United Kingdom indicates growing adoption of cloud-integrated bioinformatics systems and automated synthesis workflows. Expansion of genomics research collaborations and advanced molecular diagnostics continues to strengthen regional market demand.

Asia-Pacific

Asia-Pacific represents approximately 24% of the global gene synthesis market Share and remains one of the fastest-growing regions due to increasing biotechnology investments, expanding pharmaceutical manufacturing, and rising genomics research activity. China, Japan, India, and South Korea are major contributors to regional demand for synthetic DNA technologies.

The gene synthesis market Opportunities in Asia-Pacific are strengthened by healthcare modernization initiatives and growing investment in precision medicine. Biotechnology companies and research institutes increasingly adopt automated synthesis systems and AI-based gene design tools to accelerate therapeutic and agricultural research projects.

Japan gene synthesis market

Japan contributes approximately 18% of the Asia-Pacific gene synthesis market due to advanced biotechnology innovation and strong investment in regenerative medicine and genomics research. Pharmaceutical companies increasingly utilize synthetic biology technologies for personalized medicine and therapeutic development.

The gene synthesis market Forecast for Japan highlights rising adoption of automated laboratory systems and precision diagnostics platforms. Research organizations continue to focus on advanced molecular engineering and cell therapy applications, supporting long-term market expansion.

China gene synthesis market

China accounts for approximately 41% of the Asia-Pacific gene synthesis market Share because of rapid biotechnology infrastructure expansion and increasing government investment in genomics research. Pharmaceutical companies and biotechnology startups increasingly deploy gene synthesis technologies for vaccine development, molecular diagnostics, and agricultural biotechnology applications.

The gene synthesis market Outlook for China indicates strong growth in synthetic biology manufacturing and AI-driven bioinformatics platforms. Government healthcare reforms and precision medicine initiatives continue to create substantial opportunities for gene synthesis providers and biotechnology firms.

Rest of World

The Rest of World region accounts for approximately 7% of the global gene synthesis market and includes Latin America, the Middle East, and Africa. Increasing biotechnology awareness, rising healthcare investment, and growing genomic research activity are supporting gradual market expansion across these regions.

The gene synthesis market Opportunities in emerging economies are linked to expansion of molecular diagnostics, vaccine development, and agricultural biotechnology programs. Governments and research organizations are increasingly investing in genomics infrastructure and biotechnology education to improve innovation capabilities and healthcare outcomes.

List of Top Gene Synthesis Companies

• GenScript
• Brooks Automation, Inc. (GENEWIZ)
• Boster Biological Technology
• Twist Bioscience
• ProteoGenix, Inc
• Biomatik
• ProMab Biotechnologies, Inc.
• Thermo Fisher Scientific, Inc.
• Integrated DNA Technologies, Inc.
• OriGene Technologies, Inc.

Top two companies with the highest market share

• Twist Bioscience – 17% market share
• Thermo Fisher Scientific, Inc. – 15% market share

Investment Analysis and Opportunities

The gene synthesis market is attracting substantial investment due to rising demand for synthetic biology, precision medicine, and advanced genomic engineering. Biotechnology firms, pharmaceutical companies, and venture capital investors are heavily investing in automated DNA synthesis platforms, AI-driven bioinformatics systems, and cloud-based genomics infrastructure to improve research productivity and accelerate therapeutic innovation.

The gene synthesis market Opportunities are particularly strong in cell therapy, mRNA vaccine development, agricultural biotechnology, and CRISPR-related applications. Investors are focusing on high-throughput synthesis systems and advanced gene assembly technologies capable of supporting scalable and cost-efficient DNA production. North America and Asia-Pacific remain major investment destinations because of increasing biotechnology funding and expanding precision medicine initiatives. Companies are also investing in automated quality control systems, digital laboratory platforms, and next-generation synthesis methods designed to reduce production timelines and improve sequence accuracy. Rising demand for synthetic biology solutions across healthcare, agriculture, and industrial biotechnology continues to support long-term market expansion.

New Product Development

Innovation within the gene synthesis market is increasingly focused on AI-powered gene design, automated DNA assembly systems, and high-throughput synthetic biology platforms. Manufacturers are introducing advanced synthesis technologies capable of producing long and complex DNA sequences with improved speed and accuracy. These innovations are helping biotechnology firms accelerate therapeutic research and genomic engineering projects.

The gene synthesis market trends highlight growing development of cloud-integrated bioinformatics systems and automated sequence optimization software. Companies are investing in scalable chip-based synthesis technologies, CRISPR-compatible DNA constructs, and advanced cloning solutions designed for precision medicine and synthetic biology applications. Integration of machine learning algorithms into gene design workflows is also improving codon optimization and reducing synthesis errors. Product innovation remains critical for improving operational efficiency, research scalability, and therapeutic development timelines.

Five Recent Developments (2023-2025)

• Twist Bioscience expanded high-throughput DNA synthesis capabilities for synthetic biology and pharmaceutical applications in 2024.
• Thermo Fisher Scientific, Inc. introduced advanced automated gene assembly systems designed for precision genomics research in 2025.
• GenScript strengthened CRISPR-compatible synthetic gene services supporting cell therapy development in 2023.
• Integrated DNA Technologies, Inc. launched improved AI-driven sequence optimization tools for custom DNA synthesis projects in 2024.
• Brooks Automation, Inc. (GENEWIZ) expanded cloud-based genomics workflow platforms for biotechnology research organizations in 2025.

Report Coverage of gene synthesis market

The gene synthesis market Report provides comprehensive analysis of synthetic biology technologies, DNA synthesis methods, genomic engineering applications, and biotechnology research infrastructure across global markets. The report evaluates major synthesis methods including solid-phase synthesis, chip-based synthesis, and PCR-based enzyme synthesis while analyzing applications across therapeutics development, diagnostics, agricultural biotechnology, and academic research.

Request for Customization   to gain extensive market insights.

The gene synthesis market Research Report further covers regional demand analysis across North America, Europe, Asia-Pacific, and Rest of World markets while providing country-level insights for Germany, the United Kingdom, Japan, and China. The report examines competitive strategies, regulatory developments, investment trends, and technological advancements influencing industry growth. In addition, the analysis highlights opportunities related to AI-driven genomics, synthetic biology automation, CRISPR technologies, and personalized medicine initiatives. The report supports biotechnology companies, pharmaceutical manufacturers, investors, academic institutions, and genomics research organizations seeking strategic understanding of evolving gene synthesis industry dynamics.